SI1786790T1 - Derivati oksazola kot agenti histamin h3 receptorja, priprava in terapevtska uporaba - Google Patents
Derivati oksazola kot agenti histamin h3 receptorja, priprava in terapevtska uporabaInfo
- Publication number
- SI1786790T1 SI1786790T1 SI200530741T SI200530741T SI1786790T1 SI 1786790 T1 SI1786790 T1 SI 1786790T1 SI 200530741 T SI200530741 T SI 200530741T SI 200530741 T SI200530741 T SI 200530741T SI 1786790 T1 SI1786790 T1 SI 1786790T1
- Authority
- SI
- Slovenia
- Prior art keywords
- histamine
- nitrogen
- formula
- ring
- compounds
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Child & Adolescent Psychology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US59119104P | 2004-07-26 | 2004-07-26 | |
| EP05773290A EP1786790B1 (en) | 2004-07-26 | 2005-07-14 | Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1786790T1 true SI1786790T1 (sl) | 2009-10-31 |
Family
ID=35134220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200530741T SI1786790T1 (sl) | 2004-07-26 | 2005-07-14 | Derivati oksazola kot agenti histamin h3 receptorja, priprava in terapevtska uporaba |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US7666871B2 (sl) |
| EP (1) | EP1786790B1 (sl) |
| JP (1) | JP4982367B2 (sl) |
| CN (1) | CN1989115B (sl) |
| AT (1) | ATE432926T1 (sl) |
| AU (1) | AU2005275183B2 (sl) |
| BR (1) | BRPI0513777A (sl) |
| CA (1) | CA2575081C (sl) |
| CY (1) | CY1109493T1 (sl) |
| DE (1) | DE602005014786D1 (sl) |
| DK (1) | DK1786790T3 (sl) |
| ES (1) | ES2325865T3 (sl) |
| MX (1) | MX2007001029A (sl) |
| PL (1) | PL1786790T3 (sl) |
| PT (1) | PT1786790E (sl) |
| SI (1) | SI1786790T1 (sl) |
| WO (1) | WO2006019833A1 (sl) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8008301B2 (en) * | 2004-04-01 | 2011-08-30 | Eli Lilly And Company | Histamine H3 receptor agents, preparation and therapeutic uses |
| WO2006089076A2 (en) | 2005-02-18 | 2006-08-24 | Neurogen Corporation | Thiazole amides, imidazole amides and related analogues |
| US7790720B2 (en) * | 2005-03-31 | 2010-09-07 | Ucb Pharma, S.A. | Compounds comprising an oxazole or thiazole moiety, processes for making them, and their uses |
| MY153720A (en) | 2005-11-15 | 2015-03-13 | Otsuka Pharma Co Ltd | Oxazole compound and pharmaceutical composition |
| AU2007227681A1 (en) | 2006-03-15 | 2007-09-27 | Wyeth | N-substituted-azacyclylamines as histamine-3 antagonists |
| EP2024327A1 (de) * | 2006-05-19 | 2009-02-18 | Basf Se | Benzoylsubstituierte alanine |
| CN101432261A (zh) | 2006-05-19 | 2009-05-13 | 惠氏公司 | 作为组织胺-3拮抗剂的n-苯甲酰基-吡咯烷-3-基胺和n-苄基-吡咯烷-3-基胺 |
| US8329159B2 (en) * | 2006-08-11 | 2012-12-11 | Bristol-Myers Squibb Company | Hepatitis C virus inhibitors |
| PE20081152A1 (es) | 2006-10-06 | 2008-08-10 | Wyeth Corp | Azaciclilaminas n-sustituidas como antagonistas de histamina-3 |
| AR067549A1 (es) * | 2007-07-16 | 2009-10-14 | Wyeth Corp | Compuesto de oxazol,tiazol e imidazol, composicion farmaceutica que lo comprende , proceso para la preparacion del compuesto , uso del compuesto y metodos para la inhibicion del receptor h3 y para el tratamiento de un trastorno cognitivo relacionado con o afectado por el receptor de histamina -3 (h3 |
| WO2009126782A1 (en) * | 2008-04-11 | 2009-10-15 | High Point Pharmaceuticals, Llc | Histamine h3 receptor ligands |
| US8383829B2 (en) * | 2008-04-15 | 2013-02-26 | Konica Minolta Holdings, Inc. | Electrochromic compound, electrode, and display element |
| SA110310332B1 (ar) * | 2009-05-01 | 2013-12-10 | Astrazeneca Ab | مركبات ميثانون (3 استبدال -ازيتيدين -1-يل )(5- فينيل -1، 3، 4- أوكساديازول -2-يل ) |
| KR20130041177A (ko) | 2010-07-06 | 2013-04-24 | 아스트라제네카 아베 | 치료제 976 |
| UY34194A (es) | 2011-07-15 | 2013-02-28 | Astrazeneca Ab | ?(3-(4-(espiroheterocíclico)metil)fenoxi)azetidin-1-il)(5-(fenil)-1,3,4-oxadiazol-2-il)metanona en el tratamiento de la obesidad? |
| WO2013151982A1 (en) | 2012-04-03 | 2013-10-10 | Arena Pharmaceuticals, Inc. | Methods and compounds useful in treating pruritus, and methods for identifying such compounds |
| BR112015017331B1 (pt) | 2013-01-23 | 2022-01-11 | Astrazeneca Ab | Compostos de formula i, forma cristalina, uso dos compostos, combinação e composição |
| EP3233828B1 (en) * | 2014-12-18 | 2020-03-04 | F. Hoffmann-La Roche AG | Estrogen receptor modulators and uses thereof |
| MX2017014956A (es) | 2015-06-03 | 2018-04-13 | Squibb Bristol Myers Co | Agonistas de receptor de apelina (apj) de 4-hidroxi-3-(heteroaril) piridin-2-ona como para uso en el tratamiento de trastornos cardiovasculares. |
| PL3319959T3 (pl) | 2015-07-06 | 2022-02-14 | Alkermes, Inc. | Hetero-haloinhibitory deacetylazy histonowej |
| WO2017007755A1 (en) | 2015-07-06 | 2017-01-12 | Rodin Therapeutics, Inc. | Heterobicyclic n-aminophenyl-amides as inhibitors of histone deacetylase |
| EP3568135B1 (en) | 2017-01-11 | 2021-04-07 | Alkermes, Inc. | Bicyclic inhibitors of histone deacetylase |
| JP7152471B2 (ja) | 2017-08-07 | 2022-10-12 | ロダン・セラピューティクス，インコーポレーテッド | ヒストン脱アセチル化酵素の二環阻害剤 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3819037A1 (de) * | 1988-06-04 | 1989-12-14 | Hoechst Ag | 2,4-disubstituierte oxazol-derivate, verfahren zu ihrer herstellung sowie ihre verwendung als therapiemittel gegen krankheiten, die durch rhinoviren verursacht werden |
| WO1995009159A1 (en) * | 1993-09-28 | 1995-04-06 | Otsuka Pharmaceutical Company, Limited | Quinoxaline derivative as antidiabetic agent |
| AU3957600A (en) * | 1999-04-26 | 2000-11-10 | Boehringer Ingelheim International Gmbh | Piperidyl-imidazole derivatives, their preparations and therapeutic uses |
| EP1379493A2 (en) | 2001-03-23 | 2004-01-14 | Eli Lilly and Company | Non-imidazole aryl alkylamines compounds as histamine h3 receptor antagonists, preparation and therapeutic uses |
| RU2366652C2 (ru) | 2002-02-01 | 2009-09-10 | ХАЙ ПОЙНТ ФАРМАСЬЮТИКАЛЗ, ЭлЭлСи | Амиды аминоалкилзамещенных азетидинов, пирролидинов, пиперидинов и азепанов |
| DE10259244A1 (de) * | 2002-12-17 | 2004-07-01 | Merck Patent Gmbh | N-(Indolethyl-)cycloamin-Verbindungen |
| US7332508B2 (en) | 2002-12-18 | 2008-02-19 | Novo Nordisk A/S | Substituted homopiperidine, piperidine or pyrrolidine derivatives |
| US7259262B2 (en) * | 2003-10-24 | 2007-08-21 | Hoffmann-La Roche Inc. | Arylazole derivatives, their manufacture and use as pharmaceutical agents |
-
2005
- 2005-07-14 DE DE602005014786T patent/DE602005014786D1/de active Active
- 2005-07-14 CA CA2575081A patent/CA2575081C/en not_active Expired - Fee Related
- 2005-07-14 EP EP05773290A patent/EP1786790B1/en not_active Not-in-force
- 2005-07-14 CN CN200580024874XA patent/CN1989115B/zh not_active Expired - Fee Related
- 2005-07-14 JP JP2007523605A patent/JP4982367B2/ja not_active Expired - Fee Related
- 2005-07-14 WO PCT/US2005/024883 patent/WO2006019833A1/en active Application Filing
- 2005-07-14 DK DK05773290T patent/DK1786790T3/da active
- 2005-07-14 PT PT05773290T patent/PT1786790E/pt unknown
- 2005-07-14 BR BRPI0513777-2A patent/BRPI0513777A/pt not_active IP Right Cessation
- 2005-07-14 MX MX2007001029A patent/MX2007001029A/es active IP Right Grant
- 2005-07-14 US US11/572,283 patent/US7666871B2/en not_active Expired - Fee Related
- 2005-07-14 SI SI200530741T patent/SI1786790T1/sl unknown
- 2005-07-14 AU AU2005275183A patent/AU2005275183B2/en not_active Ceased
- 2005-07-14 ES ES05773290T patent/ES2325865T3/es active Active
- 2005-07-14 AT AT05773290T patent/ATE432926T1/de active
- 2005-07-14 PL PL05773290T patent/PL1786790T3/pl unknown
-
2009
- 2009-08-06 CY CY20091100831T patent/CY1109493T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2006019833A1 (en) | 2006-02-23 |
| BRPI0513777A (pt) | 2008-05-13 |
| US7666871B2 (en) | 2010-02-23 |
| CN1989115B (zh) | 2012-03-21 |
| CA2575081A1 (en) | 2006-02-23 |
| ES2325865T3 (es) | 2009-09-22 |
| AU2005275183B2 (en) | 2011-03-17 |
| EP1786790A1 (en) | 2007-05-23 |
| ATE432926T1 (de) | 2009-06-15 |
| CA2575081C (en) | 2013-05-07 |
| JP4982367B2 (ja) | 2012-07-25 |
| JP2008507579A (ja) | 2008-03-13 |
| PT1786790E (pt) | 2009-08-18 |
| CY1109493T1 (el) | 2014-08-13 |
| PL1786790T3 (pl) | 2009-10-30 |
| US20070197604A1 (en) | 2007-08-23 |
| MX2007001029A (es) | 2007-04-12 |
| DK1786790T3 (da) | 2009-07-20 |
| DE602005014786D1 (de) | 2009-07-16 |
| EP1786790B1 (en) | 2009-06-03 |
| CN1989115A (zh) | 2007-06-27 |
| AU2005275183A1 (en) | 2006-02-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL1786790T3 (pl) | Pochodne oksazolu jako środki receptora histaminowego H3, ich wytwarzanie i terapeutyczne zastosowanie | |
| TWI262917B (en) | 2-Furancarboxylic hydrazides and pharmaceutical compositions containing the same | |
| PL1735278T3 (pl) | Związki receptora histaminowego H3, wytwarzanie i zastosowania terapeutyczne | |
| NZ588121A (en) | Novel estrogen receptor ligands | |
| TW200716528A (en) | Cyclopropanecarboxamide derivatives | |
| MY142807A (en) | Benzimidazole derivative and use thereof. | |
| MX2007008614A (es) | Peptidos con actividad agonista del receptor del neuropeptido-2 (y2r). | |
| GEP20084527B (en) | Benzimidazolone compounds having 5-ht4 receptor agonistic activity | |
| MX2007005709A (es) | Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida sustituidos. | |
| NZ548196A (en) | Aryl aniline derivatives as beta2 adrenergic receptor agonists | |
| PT1828177E (pt) | Novos antagonistas dos receptores da mch | |
| TW200726765A (en) | Triazolopyridine cannabinoid receptor 1 antagonists | |
| GB0701366D0 (en) | Novel pharmaceutical compositions | |
| ATE457988T1 (de) | A2a-adenosin-rezeptor-antagonisten | |
| MXPA05007115A (es) | Nuevos agonistas inversos del receptor cb 1. | |
| GB0701365D0 (en) | Novel pharmaceutical compositions | |
| MX2010006230A (es) | Derivados de arilamida substituidos con triazol y su uso como antagonistas de receptor purinergico p2x3 y/o p2x2/3. | |
| CY1109694T1 (el) | Παραγωγα πυρρολιδινης ως ανταγωνιστες υποδοχεα η3 ισταμινης | |
| JP2010513489A5 (sl) | ||
| ATE523488T1 (de) | Histamin-h3-rezeptor-mittel, deren herstellung und therapeutische verwendung | |
| EA201071259A1 (ru) | Спиро(пиперидин-4,2-пирролидин)-1-(3,5-трифторметилфенил)метилкарбоксамиды в качестве антагонистов рецептора nk1 тахикинина | |
| TNSN08093A1 (en) | Quinoline derivatives and use as antitumor agents |